HGHRX Performance — The Hartford Healthcare Fund, Class R3
Data updated: 2026-09-29
HGHRX returned +4.69% year to date and +31.76% over one year to Jul 2026. Annualised returns are +7.12% over 3 years and +1.88% over 5 years. The fund trailed its Health Care Equity category average: $100 invested three years ago grew to $123, against $137 for the category, and to $132 over one year, against $137. Volatility over the past three years was 14.90% a year. In the 12 months to Jul 2026 the fund lost a net $152.1M, and assets reached $772.21M.
HGHRX Growth of $100
What $100 invested in The Hartford Healthcare Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.
| Period | HGHRX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $132 | $137 |
| 3 years (Aug 2023 – Jul 2026) | $123 | $137 |
| 5 years (Aug 2021 – Jul 2026) | $110 | $121 |
| Since data start (Aug 2019 – Jul 2026) | $169 | $183 |
HGHRX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +4.69% |
| 1 year | +31.76% |
| 3 years (annualised) | +7.12% |
| 5 years (annualised) | +1.88% |
HGHRX Annual Returns
Calendar-year total returns of The Hartford Healthcare Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +4.69% |
| 2025 | +15.22% |
| 2024 | −0.35% |
| 2023 | +3.44% |
| 2022 | −12.03% |
| 2021 | +9.58% |
| 2020 | +22.18% |
| 2019 (Aug–Dec) | +15.52% |
HGHRX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −0.5% | +1.7% | −6.3% | +0.7% | +2.3% | +7.7% | −0.5% | — | — | — | — | — |
| 2025 | +6.0% | −1.8% | −3.5% | −1.7% | −5.7% | +1.7% | −3.3% | +5.0% | +4.0% | +6.1% | +9.7% | −1.0% |
| 2024 | +1.4% | +3.7% | +2.1% | −4.4% | +2.2% | +2.0% | +2.4% | +6.0% | −2.7% | −5.6% | +0.1% | −6.6% |
| 2023 | −0.6% | −4.7% | +1.5% | +4.0% | −2.7% | +4.4% | −0.4% | −1.4% | −4.3% | −3.8% | +6.6% | +5.7% |
| 2022 | −10.8% | +0.3% | +3.1% | −7.8% | −0.4% | −1.7% | +4.8% | −5.8% | −3.5% | +7.5% | +4.9% | −1.8% |
| 2021 | +1.6% | −2.1% | −0.2% | +4.5% | 0.0% | +3.8% | +1.2% | +2.3% | −5.5% | +2.7% | −5.0% | +6.4% |
| 2020 | −2.0% | −5.0% | −7.0% | +14.1% | +6.2% | −0.2% | +3.4% | +3.4% | −0.9% | −2.3% | +8.3% | +4.3% |
| 2019 | — | — | — | — | — | — | — | −1.5% | −1.7% | +6.1% | +7.8% | +4.4% |
HGHRX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 14.90%
- 3-year Sharpe ratio: 0.18 (vs 4.5% risk-free rate)
- Best month: +9.74% (Nov 2025)
- Worst month: −6.59% (Dec 2024)
HGHRX Fund Flows
Monthly money in and out of The Hartford Healthcare Fund, from SEC Form N-PORT.
- 12-month net flow: −$152.1M
- 12-month gross sales (incl. reinvestments): $78.0M
- Sales ÷ redemptions: 0.34×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $4.2M | $9.0M | −$4.8M |
| Jun 2026 | $3.2M | $12.0M | −$8.8M |
| May 2026 | $2.8M | $15.7M | −$12.9M |
| Apr 2026 | $2.3M | $17.6M | −$15.3M |
| Mar 2026 | $3.7M | $50.6M | −$46.9M |
| Feb 2026 | $4.3M | $15.4M | −$11.1M |
| Jan 2026 | $7.3M | $14.7M | −$7.4M |
| Dec 2025 | $34.0M | $17.9M | $16.1M |
| Nov 2025 | $5.1M | $15.4M | −$10.3M |
| Oct 2025 | $3.2M | $19.5M | −$16.3M |
| Sep 2025 | $3.3M | $20.6M | −$17.3M |
| Aug 2025 | $4.4M | $21.6M | −$17.2M |
HGHRX Assets Under Management
Net assets of The Hartford Healthcare Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $772.21M |
| 2026-04-30 | $729.19M |
| 2026-01-31 | $834.13M |
| 2025-10-31 | $800.04M |
| 2025-07-31 | $737.39M |
| 2025-04-30 | $861.87M |
| 2025-01-31 | $983.40M |
| 2024-10-31 | $1.04B |
| 2024-07-31 | $1.10B |
| 2024-04-30 | $1.07B |
| 2024-01-31 | $1.15B |
| 2023-10-31 | $1.07B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.